[CYCC] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
31-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -90.95%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 0 843 1,944 1,734 1,084 69 699 -
PBT -8,463 -13,774 -16,486 -22,649 -11,880 -15,107 -15,808 -9.88%
Tax -993 -1,983 -2,144 -3,243 -1,670 -1,351 -565 9.84%
NP -7,470 -11,791 -14,342 -19,387 -10,153 -13,186 -15,243 -11.19%
Tax Rate - - - - - - - -
Total Cost 7,470 12,634 16,286 21,121 11,237 13,255 15,942 -11.85%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin 0.00 -1,398.70 -737.76 -1,118.05 -936.62 -19,110.14 -2,180.69 -
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -19.58 -68.85 -105.72 -211.93 -160.75 -440.40 -509.10 -41.87%
EPS Diluted -19.58 -68.85 -105.72 -211.93 -160.75 -440.40 -509.10 -41.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.